Company Name | SPERA PHARMA, Inc. |
---|---|
Representative | Keitaro Iwaki, President & Representative Director |
Establishment | Apr, 2017 |
Business Started | July, 2017 |
Paid in Capital | 310 million yen |
Shareholder | Astena Holdings Co., Ltd. 100% |
Address | 17-85 Jusohonmachi 2-chome, Yodogawa-ku, Osaka 532-0024, Japan |
TEL | +81-6-7653-6818 |
Business | Pharmaceuticals Contract R&D and Manufacturing |
Number of Employees | 249 (As of December 1, 2024) |
Directors | Keitaro Iwaki, President & Representative Director Makoto Fukuta, Board Director Rami Suzuki, Outside Director |
Auditor | Toshimitsu Isobe, Audit & Supervisory Board Member |
Affiliated Companies | SPERA NEXUS, Inc. JITSUBO Co., Ltd.IWAKI SEIYAKU SAKURA FACTORY CO., LTD. |
page top